Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Synthetic peptide sensitizes leukemia cell lines to hyperthermia

March 13, 2002

Remedyne licenses Bayer antigen for use in cancer immunotherapeutic

March 13, 2002

Oncolytics Biotech files IND for clinical trial of Reolysin in recurrent malignant glioma

March 12, 2002

Phase IIa trial of PCK-3145 in prostate cancer cleared by MCA

March 12, 2002

New combination treatment for advanced hepatocellular carcinoma is safe, beneficial

March 12, 2002

Patient enrollment target met in phase II/III trial of Onco TCS in relapsed aggressive NHL

March 12, 2002

Metvix PDT receives marketing authorization in Germany

March 12, 2002

Angiogenesis inhibitors described by researchers at Angiogene Pharmaceuticals

March 11, 2002

Rubitecan receives brand name Orathecin

March 11, 2002

Fast track designation for CCI-779 in renal cell carcinoma

March 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...